Retracted: Effects of CIK Cell Therapy Combined with Camrelizumab on the Quality of Life in Patients with Nasopharyngeal Carcinoma and Analysis of Prognostic Factors

Detalles Bibliográficos
Autor principal: Neuroscience, Computational Intelligence and
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807300/
https://www.ncbi.nlm.nih.gov/pubmed/36601276
http://dx.doi.org/10.1155/2022/9854614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807300/
https://www.ncbi.nlm.nih.gov/pubmed/36601276
http://dx.doi.org/10.1155/2022/9854614

Ejemplares similares